Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Applying LC-MS/MS techniques to the development of biologics

4 May 2018
General interest

PPD® Laboratories’ Unique Approach to Biologics
For three decades, PPD Laboratories has been developing and validating bioanalytical assays for all
phases of pharmaceutical development across a wide variety

Please click here to download PPD Laboratories tech sheet on applying LC-MS/MS techniques to the development of biologics.

 

Top content

  • The capabilities of KCAS Bio: PK, biomarkers and immunogenicity testing all under one roof
  • 2025 AAPS National Biotechnology Conference round-up
  • Go with your gut: novel biosensor SENSBIT mimics the gut’s defenses

Related tags

LC-MS LC–MS/MS pharmaceuticals PPD quantification
Previous article

Related articles

13 DEC 2012 EXPERT OPINION

Revolutionizing SPE for improved bioanalysis

23 SEP 2024 JOURNAL ARTICLES

Observations from a decade of oligonucleotide bioanalysis by LC–MS

31 OCT 2011 CLINICAL

The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples

19 MAY 2011 CHROMATOGRAPHY

Clinical evaluation of the determination of plasma concentrations of darunavir, etravirine, raltegravir and ritonavir in dried blood spot samples

28 JUN 2016 LBA

Hybrid LBA/LC–MS survey infographic

26 JAN 2016 BIOPHARMACEUTICALS

Minimalistic sample preparation strategies for LC–MS quantification of large molecule biopharmaceuticals: a case study highlighting alpha-1 antitrypsin protein

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone